EYPT
EyePoint Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$12.66-4.81%
Price as of Jul 20, 2026
EYPT capital
EyePoint Pharmaceuticals, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.10x
- Net debt / equity
- -0.24x
- Debt / assets
- 0.08x
- Debt / EBITDA
- -0.09x
- Net debt / EBITDA
- 0.21x
Liquidity & coverage
- Current ratio
- 6.66x
- Quick ratio
- 6.63x
- Cash ratio
- 5.94x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $212.0M
Cash & dividend
- FCF / debt
- -12.17x
- Cash flow / debt
- -11.99x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.